Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $1,332 |
| Triangulated Fair Value | $1,089 |
| 12-mo Scenario PWEV | $1,310 |
| Implied Return | -18% |
| Forward P/E | 29.5x |
| Market Cap | $75B |
| 52-Week Range | $1,124 – $1,512 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Re-Rate' (8% weight) — targets $2,317, +74% vs spot. It needs the multiple to hold or expand.
The dashboard below is the whole argument on one page: spot ($1,332) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Defense-Budget Cuts / Aero-Production Halt' (20%) — targets $576, -57% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
P/E Multiple explains 75% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.21 vs analyst floor +0.04 → delta +0.17 (n=32 mgmt / 23 Q&A; 9th pctile across the S&P book, z -1.3).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.21 | +0.04 | +0.17 |
| 2025Q4 | +0.32 | +0.35 | -0.03 |
| 2025Q3 | +0.30 | +0.20 | +0.10 |
| 2025Q2 | +0.22 | +0.01 | +0.21 |
News (last 365d, 1000 articles): avg ticker sentiment +0.17 (bullish 20% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — Defense-Budget Cuts / Aero-Production Halt' downside ($576) to a 'Bull — Re-Rate' bull case ($2,317); the probability-weighted blend (PWEV $1,310) is -2% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Defense-Budget Cuts / Aero-Production Halt | 20% | $576 | -57% |
| Cyclical Downturn — Air-Traffic / Program Recession | 17% | $979 | -27% |
| Base — Backlog + Aftermarket | 35% | $1,359 | +2% |
| Growth — Rearmament / Air-Traffic Recovery | 20% | $1,835 | +38% |
| Bull — Re-Rate | 8% | $2,317 | +74% |
| Probability-Weighted (PWEV) | — | $1,310 | -2% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Defense-Budget Cuts / Aero-Production Halt (20%, $576). Structural impairment — defense-budget cuts / aero-production halt: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 576.24; probability: 0.2.
- Cyclical Downturn — Air-Traffic / Program Recession (17%, $979). Cyclical downturn — defense budgets + commercial-aero OE/aftermarket cycle + program execution weakens for 1–2 years before normalising. Drivers — implied_target: 978.56; probability: 0.17.
- Base — Backlog + Aftermarket (35%, $1,359). Mid-cycle — normalised defense budgets + commercial-aero OE/aftermarket cycle + program execution; disciplined capital allocation; steady returns. Drivers — implied_target: 1359.12; probability: 0.35.
- Growth — Rearmament / Air-Traffic Recovery (20%, $1,835). Upside — rearmament + air-traffic recovery lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 1834.81; probability: 0.2.
- Bull — Re-Rate (8%, $2,317). Upside tail — sustained tight conditions or a structural re-rate on rearmament + air-traffic recovery. Drivers — implied_target: 2317.29; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $1,181 | -11% |
| Peer P/E re-rate | multiple | $1,730 | +30% |
| Peer EV/Revenue re-rate | multiple | $458 | -66% |
| Scenario PWEV | multiple | $1,310 | -2% |
| DCF (5-year + terminal) | cash flow + terminal × | $709 | -47% |
| Triangulated (weighted) | — | $1,089 | -18% |
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $1,181 + scenario PWEV $1,310, ≈ spot); the weighted blend $1,089 (-18%) sits below it because the cash-flow DCF ($709) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $1,181 and 37% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (75% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.5%, 25x terminal FCF multiple → $709. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 38.3x) implies $1,730. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Aerospace & Defense | $9.5B | 100% | 7% | 30% | 29x | 4% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | defense budgets + commercial-aero OE/aftermarket cycle + program execution |
| net_debt_or_cash_b | -28.12 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | 0.0 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | defense-budget cuts / aero-production halt |
| upside | rearmament + air-traffic recovery |
Industry Context — Ind Aero Defense
This name sits in the Ind Aero Defense as a aerospace_defense. defense budgets + commercial-aero OE/aftermarket cycle + program execution Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: GE (aerospace_defense) · RTX (aerospace_defense) · LMT (aerospace_defense) · HWM (aerospace_defense) · GD (aerospace_defense) · TDG (aerospace_defense) · NOC (aerospace_defense) · LHX (aerospace_defense) · AXON (aerospace_defense) · TXT (aerospace_defense) · LDOS (aerospace_defense) · HII (aerospace_defense)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Defense-Budget Cuts / Aero-Production Halt | 37% | 37% | |
| Mid-Cycle — Backlog + Aftermarket | 35% | 35% | |
| Upside — Rearmament / Air-Traffic Recovery | 28% | 28% |
On the cluster's key downside — Defense-Budget Cuts / Aero-Production Halt () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The ind_aero_defense cycle is the shared macro driver. Driver — defense budgets + commercial-aero OE/aftermarket cycle + program execution Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $10B | $3B | $0B | $0B | $3B | $2B |
| FY+2 | $11B | $3B | $0B | $0B | $3B | $2B |
| FY+3 | $11B | $4B | $0B | $0B | $3B | $2B |
| FY+4 | $12B | $4B | $0B | $0B | $3B | $2B |
| FY+5 | $12B | $4B | $0B | $0B | $3B | $2B |
| Terminal | — | — | — | — | $3B × 25x | $56B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.5% · Σ PV(FCF) $12B + PV(terminal) $56B = EV $68B; + net cash → equity $40B ÷ diluted shares 0.06B = $709/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $393/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 33% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| GE | 8.21x | 50.0x | 7% | 20% |
| RTX | 3.113x | 26.6x | 7% | 13% |
| LMT | 1.76x | 16.31x | 7% | 11% |
| HWM | 13.07x | 53.76x | 7% | 28% |
| Median | 5.6615x | 38.3x | — | — |
Peer-median fwd P/E → $1,730; EV/Rev → $458.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $709 | 41% | $292 |
| Scenario PWEV | $1,310 | 29% | $385 |
| Monte Carlo median | $1,181 | 18% | $208 |
| Peer P/E | $1,730 | 12% | $203 |
| Triangulated | — | 100% | $1,089 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 17.5x | 21.2x | 25.0x | 28.7x | 32.5x |
|---|---|---|---|---|---|
| 6% | $490 | $652 | $818 | $981 | $1,147 |
| 8% | $448 | $603 | $762 | $917 | $1,076 |
| 8% | $409 | $557 | $709 | $857 | $1,009 |
| 10% | $372 | $514 | $659 | $800 | $945 |
| 10% | $337 | $472 | $611 | $746 | $884 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $468 | $517 | $566 | $615 | $665 |
| -1.5pp | $531 | $583 | $636 | $688 | $741 |
| +0.0pp | $597 | $653 | $709 | $765 | $821 |
| +1.5pp | $666 | $726 | $786 | $846 | $906 |
| +3.0pp | $740 | $804 | $868 | $932 | $996 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $566 | $868 | $301 |
| Terminal × ±15% | $559 | $859 | $300 |
| Op margin ±3pp | $597 | $821 | $225 |
| WACC ±1pp | $659 | $762 | $104 |
| FCF conversion ±10% | $709 | $709 | $0 |
Company lever — SoP/share vs Aerospace & Defense multiple (AI re-rating) (base 29x)
| Multiple | 20.3x | 24.6x | 29.0x | 33.3x | 37.7x |
|---|---|---|---|---|---|
| SoP/share | $2,942 | $3,671 | $4,418 | $5,147 | $5,893 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 25×, FY+5 revenue $12B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
The valuation is multiple-dependent (75% of variance); a de-rating toward the DCF anchor ($709) implies -47%.
Fact / Inference / Speculation
- FACT: Spot $1,332; 52-week range $1,124–$1,512; engine rating HOLD; base-case target $1,310 (-2%).
- INFERENCE: Triangulated FV $1,089 (-18%). P/E Multiple explains 75% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
- SPECULATION: At current prices the embedded bet is that the multiple holds or expands — P/E Multiple carries 75% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $1,089 (-18% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple (75% of variance) — fundamentally a multiple/regime call. SBC runs —M TTM (disclosed in the appendix).